PUBLISHER: The Business Research Company | PRODUCT CODE: 1942528
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942528
Cardiovascular catheters are thin, flexible tubes inserted into blood vessels to perform diagnostic or therapeutic procedures within the heart and vascular system. They are vital for delivering treatments, monitoring blood flow, and assessing heart conditions, allowing minimally invasive access without the need for open surgery.
The main product categories in the cardiovascular catheters market include cardiovascular therapeutic catheters and cardiovascular diagnostic catheters. Cardiovascular therapeutic catheters are specialized devices used in minimally invasive interventions to treat cardiovascular conditions, including opening blocked arteries and correcting abnormal heart rhythms. The applications include coronary artery disease (CAD), cardiac arrhythmias, heart failure, and others, and the end users include hospitals, clinics, and ambulatory surgical centers.
Tariffs are impacting the cardiovascular catheters market by increasing costs for imported specialized materials such as advanced polymers, stent delivery components, and diagnostic catheters. Segments including therapeutic catheters like angioplasty balloons and stent delivery systems are particularly impacted, with Asia-Pacific regions such as China and India facing significant import duties. This has led to higher production costs and supply chain adjustments. On the positive side, tariffs have encouraged local manufacturing, innovation in catheter design, and investment in domestic production capabilities.
The cardiovascular catheters market research report is one of a series of new reports from The Business Research Company that provides cardiovascular catheters market statistics, including cardiovascular catheters industry global market size, regional shares, competitors with a cardiovascular catheters market share, detailed cardiovascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular catheters industry. This cardiovascular catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiovascular catheters market size has grown strongly in recent years. It will grow from $21.87 billion in 2025 to $23.83 billion in 2026 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to reliance on conventional catheter technologies, increasing prevalence of cardiovascular diseases, growing hospital and clinic infrastructure, limited access to advanced therapeutic procedures, awareness of minimally invasive cardiovascular treatments.
The cardiovascular catheters market size is expected to see strong growth in the next few years. It will grow to $33.24 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to development of advanced therapeutic and diagnostic catheters, rising demand for outpatient and ambulatory surgical interventions, integration with imaging and digital monitoring systems, increasing cardiovascular procedure volumes, adoption of biocompatible and smart catheter materials. Major trends in the forecast period include rising adoption of minimally invasive procedures, growth in coronary artery disease interventions, increasing use of electrophysiology and ablation catheters, expansion of stent delivery and angioplasty balloon applications, focus on catheter material innovation and biocompatibility.
The increasing prevalence of vascular heart diseases is anticipated to support the expansion of the cardiovascular catheter market going forward. Vascular heart diseases include conditions affecting blood vessels supplying the heart or located within the heart itself. Factors such as aging populations, lifestyle-related changes, and higher rates of diabetes and hypertension contribute to the growing prevalence of these conditions. Cardiovascular catheters assist in minimally invasive procedures used to diagnose, treat, and manage vascular heart diseases, enabling faster recovery times and improved clinical outcomes. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, cardiovascular disease-related deaths reached 931,578, with the age-adjusted death rate increasing to 233.3 per 100,000, reflecting a 4.0% year-over-year rise. Consequently, the increasing prevalence of vascular heart diseases is supporting growth across the cardiovascular catheter market.
Leading companies operating in the cardiovascular catheters market are developing innovative products incorporating advanced technologies, such as TRUEref technology, to enhance the accuracy and reliability of cardiac mapping procedures. TRUEref technology improves catheter performance by delivering accurate reference signals during cardiac mapping, enabling precise arrhythmia identification and more targeted treatment. For example, in July 2023, Biosense Webster Inc., a US-based company within Johnson & Johnson MedTech, launched the OPTRELL mapping catheter. This high-density diagnostic catheter, powered by the CARTO 3 System, features TRUEref technology and 48 small electrodes to deliver high-definition electrophysiological mapping, allowing clinicians to map complex arrhythmias with greater precision and develop more effective ablation strategies.
In April 2023, Abbott, a US-based medical device company, acquired Cardiovascular Systems Inc. for $890 million. This acquisition is intended to enhance Abbott's vascular device portfolio by incorporating Cardiovascular Systems' innovative atherectomy systems, thereby improving treatment options for peripheral and coronary artery diseases. The transaction enables Abbott to deliver more comprehensive care to patients with complex arterial conditions. Cardiovascular Systems Inc. is a US-based medical equipment manufacturer specializing in catheters and related devices for vascular disease treatment.
Major companies operating in the cardiovascular catheters market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., ZOLL Medical Corporation, Nipro Corporation, Cook Group Incorporated, Biotronik SE & Co. KG, Merit Medical Systems Inc., LivaNova plc, Cordis Corporation, Asahi Intecc Co. Ltd., AngioDynamics Inc., Endologix Inc., Wellinq, Cardionovum GmbH, Avinger Inc., CathRx, Andocor NV
Asia-Pacific was the largest region in the cardiovascular catheters market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiovascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiovascular catheters market consists of sales of balloon catheters and electrophysiology catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiovascular Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiovascular catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiovascular catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular catheters market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.